GlassScriptPhysician profile
Gerald W Moritz
NPI 1154418424
$1,634.89
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $292 · 2021: $482 · 2022: $539.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $664.47 | 2020-2022 | |
| Stryker Corporation | $258.62 | 2019-2022 | |
| Integra Lifesciences Corporation | $223.65 | 2019-2021 | |
| Medtronic, INC. | $108.35 | 2022 | |
| Kerecis Limited | $80.09 | 2022 | |
| Hydrofera LLC | $78.86 | 2022 | |
| Aroa Biosurgery Incorporated | $54.59 | 2019-2020 | |
| Allergan, INC. | $38.33 | 2019-2020 | |
| Acclarent, INC | $32.74 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $26.40 | 2020-2021 | |
| Shionogi INC | $23.56 | 2021 | |
| Apria Healthcare LLC | $20.04 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.79 | 2019 | |
| Paratek Pharmaceuticals, INC. | $12.40 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Moritz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.